jurkat atcc cat Search Results


99
ATCC cell lines jurkat e6 1 atcc cat
Cell Lines Jurkat E6 1 Atcc Cat, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+atcc+cat/293T/pm40345188-287-58-62
Average 99 stars, based on 1 article reviews
cell lines jurkat e6 1 atcc cat - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

93
ATCC fas associated death domain fadd protein
( A) Wild-type E6-1 leukemia cells and dominant-negative Fas-associated via death domain (DN <t>FADD)</t> leukemia cells were treated with the indicated drug at the indicated dose for 48 hours and the WST-1 reagent was used to quantify proliferation. Absorbance was read at 450 nm and expressed as a % of DMSO control. (B, C) Cells were treated for either (B) 24 hours or (C) 48 hours and were probed with annexin V and propidium iodide (PI). Percentage of annexin V and PI positive cells was quantified using image-based cytometry. Blue bar represents viable cells; orange bar represents PI and annexin V positive cells; green bar represents annexin V positive cells; red bar represents PI positive cells. Values are expressed as mean ± SD from three independent experiments. * p < 0.05 vs. DMSO control; **** p < 0.0001 vs. DMSO control.
Fas Associated Death Domain Fadd Protein, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+atcc+cat/I+2%2E1/pmc05333808-54-27-34
Average 93 stars, based on 1 article reviews
fas associated death domain fadd protein - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

99
ATCC cclv rie 0350 rrid cvcl c190 human jurkat
( A) Wild-type E6-1 leukemia cells and dominant-negative Fas-associated via death domain (DN <t>FADD)</t> leukemia cells were treated with the indicated drug at the indicated dose for 48 hours and the WST-1 reagent was used to quantify proliferation. Absorbance was read at 450 nm and expressed as a % of DMSO control. (B, C) Cells were treated for either (B) 24 hours or (C) 48 hours and were probed with annexin V and propidium iodide (PI). Percentage of annexin V and PI positive cells was quantified using image-based cytometry. Blue bar represents viable cells; orange bar represents PI and annexin V positive cells; green bar represents annexin V positive cells; red bar represents PI positive cells. Values are expressed as mean ± SD from three independent experiments. * p < 0.05 vs. DMSO control; **** p < 0.0001 vs. DMSO control.
Cclv Rie 0350 Rrid Cvcl C190 Human Jurkat, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+atcc+cat/Jurkat%2C+Clone+E6-1/pm28636952-200-3-13
Average 99 stars, based on 1 article reviews
cclv rie 0350 rrid cvcl c190 human jurkat - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

96
ATCC jurkat cells
( A) Wild-type E6-1 leukemia cells and dominant-negative Fas-associated via death domain (DN <t>FADD)</t> leukemia cells were treated with the indicated drug at the indicated dose for 48 hours and the WST-1 reagent was used to quantify proliferation. Absorbance was read at 450 nm and expressed as a % of DMSO control. (B, C) Cells were treated for either (B) 24 hours or (C) 48 hours and were probed with annexin V and propidium iodide (PI). Percentage of annexin V and PI positive cells was quantified using image-based cytometry. Blue bar represents viable cells; orange bar represents PI and annexin V positive cells; green bar represents annexin V positive cells; red bar represents PI positive cells. Values are expressed as mean ± SD from three independent experiments. * p < 0.05 vs. DMSO control; **** p < 0.0001 vs. DMSO control.
Jurkat Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+atcc+cat/J%2ERT3-T3%2E5/us11613764-1083-1-3
Average 96 stars, based on 1 article reviews
jurkat cells - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
ATCC jurkat a3 permanent human t cell line
( A) Wild-type E6-1 leukemia cells and dominant-negative Fas-associated via death domain (DN <t>FADD)</t> leukemia cells were treated with the indicated drug at the indicated dose for 48 hours and the WST-1 reagent was used to quantify proliferation. Absorbance was read at 450 nm and expressed as a % of DMSO control. (B, C) Cells were treated for either (B) 24 hours or (C) 48 hours and were probed with annexin V and propidium iodide (PI). Percentage of annexin V and PI positive cells was quantified using image-based cytometry. Blue bar represents viable cells; orange bar represents PI and annexin V positive cells; green bar represents annexin V positive cells; red bar represents PI positive cells. Values are expressed as mean ± SD from three independent experiments. * p < 0.05 vs. DMSO control; **** p < 0.0001 vs. DMSO control.
Jurkat A3 Permanent Human T Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+atcc+cat/A3/us08907063-223-12-21
Average 96 stars, based on 1 article reviews
jurkat a3 permanent human t cell line - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

90
ATCC human jurkat cells
( A) Wild-type E6-1 leukemia cells and dominant-negative Fas-associated via death domain (DN <t>FADD)</t> leukemia cells were treated with the indicated drug at the indicated dose for 48 hours and the WST-1 reagent was used to quantify proliferation. Absorbance was read at 450 nm and expressed as a % of DMSO control. (B, C) Cells were treated for either (B) 24 hours or (C) 48 hours and were probed with annexin V and propidium iodide (PI). Percentage of annexin V and PI positive cells was quantified using image-based cytometry. Blue bar represents viable cells; orange bar represents PI and annexin V positive cells; green bar represents annexin V positive cells; red bar represents PI positive cells. Values are expressed as mean ± SD from three independent experiments. * p < 0.05 vs. DMSO control; **** p < 0.0001 vs. DMSO control.
Human Jurkat Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+atcc+cat/Sclerotium+rolfsii/pm33247137-181-0-5
Average 90 stars, based on 1 article reviews
human jurkat cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

91
ATCC neo jurkat
( A) Wild-type E6-1 leukemia cells and dominant-negative Fas-associated via death domain (DN <t>FADD)</t> leukemia cells were treated with the indicated drug at the indicated dose for 48 hours and the WST-1 reagent was used to quantify proliferation. Absorbance was read at 450 nm and expressed as a % of DMSO control. (B, C) Cells were treated for either (B) 24 hours or (C) 48 hours and were probed with annexin V and propidium iodide (PI). Percentage of annexin V and PI positive cells was quantified using image-based cytometry. Blue bar represents viable cells; orange bar represents PI and annexin V positive cells; green bar represents annexin V positive cells; red bar represents PI positive cells. Values are expressed as mean ± SD from three independent experiments. * p < 0.05 vs. DMSO control; **** p < 0.0001 vs. DMSO control.
Neo Jurkat, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+atcc+cat/CATH%2Ea%3B+Neuron%3B+Mouse/us11136401-161-28-30
Average 91 stars, based on 1 article reviews
neo jurkat - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

crl  (ATCC)
94
ATCC crl
( A) Wild-type E6-1 leukemia cells and dominant-negative Fas-associated via death domain (DN <t>FADD)</t> leukemia cells were treated with the indicated drug at the indicated dose for 48 hours and the WST-1 reagent was used to quantify proliferation. Absorbance was read at 450 nm and expressed as a % of DMSO control. (B, C) Cells were treated for either (B) 24 hours or (C) 48 hours and were probed with annexin V and propidium iodide (PI). Percentage of annexin V and PI positive cells was quantified using image-based cytometry. Blue bar represents viable cells; orange bar represents PI and annexin V positive cells; green bar represents annexin V positive cells; red bar represents PI positive cells. Values are expressed as mean ± SD from three independent experiments. * p < 0.05 vs. DMSO control; **** p < 0.0001 vs. DMSO control.
Crl, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+atcc+cat/P116/pmc09407655__pnas__2201541119__sapp-197-188-186
Average 94 stars, based on 1 article reviews
crl - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
CLS Cell Lines Service GmbH jurkat
( A) Wild-type E6-1 leukemia cells and dominant-negative Fas-associated via death domain (DN <t>FADD)</t> leukemia cells were treated with the indicated drug at the indicated dose for 48 hours and the WST-1 reagent was used to quantify proliferation. Absorbance was read at 450 nm and expressed as a % of DMSO control. (B, C) Cells were treated for either (B) 24 hours or (C) 48 hours and were probed with annexin V and propidium iodide (PI). Percentage of annexin V and PI positive cells was quantified using image-based cytometry. Blue bar represents viable cells; orange bar represents PI and annexin V positive cells; green bar represents annexin V positive cells; red bar represents PI positive cells. Values are expressed as mean ± SD from three independent experiments. * p < 0.05 vs. DMSO control; **** p < 0.0001 vs. DMSO control.
Jurkat, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+atcc+cat/Jurkat+E6%2E1+Cells/pm35220044-73-15-34
Average 94 stars, based on 1 article reviews
jurkat - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

99
ATCC bcl 2 jurkat cell line
( A) Wild-type E6-1 leukemia cells and dominant-negative Fas-associated via death domain (DN <t>FADD)</t> leukemia cells were treated with the indicated drug at the indicated dose for 48 hours and the WST-1 reagent was used to quantify proliferation. Absorbance was read at 450 nm and expressed as a % of DMSO control. (B, C) Cells were treated for either (B) 24 hours or (C) 48 hours and were probed with annexin V and propidium iodide (PI). Percentage of annexin V and PI positive cells was quantified using image-based cytometry. Blue bar represents viable cells; orange bar represents PI and annexin V positive cells; green bar represents annexin V positive cells; red bar represents PI positive cells. Values are expressed as mean ± SD from three independent experiments. * p < 0.05 vs. DMSO control; **** p < 0.0001 vs. DMSO control.
Bcl 2 Jurkat Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+atcc+cat/BCL2+Jurkat/pmc05430918-375-1-5
Average 99 stars, based on 1 article reviews
bcl 2 jurkat cell line - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

Image Search Results


( A) Wild-type E6-1 leukemia cells and dominant-negative Fas-associated via death domain (DN FADD) leukemia cells were treated with the indicated drug at the indicated dose for 48 hours and the WST-1 reagent was used to quantify proliferation. Absorbance was read at 450 nm and expressed as a % of DMSO control. (B, C) Cells were treated for either (B) 24 hours or (C) 48 hours and were probed with annexin V and propidium iodide (PI). Percentage of annexin V and PI positive cells was quantified using image-based cytometry. Blue bar represents viable cells; orange bar represents PI and annexin V positive cells; green bar represents annexin V positive cells; red bar represents PI positive cells. Values are expressed as mean ± SD from three independent experiments. * p < 0.05 vs. DMSO control; **** p < 0.0001 vs. DMSO control.

Journal: PLoS ONE

Article Title: Structurally simplified biphenyl combretastatin A4 derivatives retain in vitro anti-cancer activity dependent on mitotic arrest

doi: 10.1371/journal.pone.0171806

Figure Lengend Snippet: ( A) Wild-type E6-1 leukemia cells and dominant-negative Fas-associated via death domain (DN FADD) leukemia cells were treated with the indicated drug at the indicated dose for 48 hours and the WST-1 reagent was used to quantify proliferation. Absorbance was read at 450 nm and expressed as a % of DMSO control. (B, C) Cells were treated for either (B) 24 hours or (C) 48 hours and were probed with annexin V and propidium iodide (PI). Percentage of annexin V and PI positive cells was quantified using image-based cytometry. Blue bar represents viable cells; orange bar represents PI and annexin V positive cells; green bar represents annexin V positive cells; red bar represents PI positive cells. Values are expressed as mean ± SD from three independent experiments. * p < 0.05 vs. DMSO control; **** p < 0.0001 vs. DMSO control.

Article Snippet: E6-1 jurkat cells (ATCC, Cat. No. TIB-152, Manassas, VA, USA), an acute T-cell leukemia cell line, as well as a jurkat cell line dominant negative for the Fas-Associated Death Domain (FADD) protein (DN-FADD Jurkat; ATCC, Cat. No. CRL-2572, Manassas, VA, USA), were cultured with RPMI-1640 (Sigma-Aldrich Canada, Mississauga, ON, Canada) supplemented with 10% (v/v) FBS standard (Thermo Scientific, Waltham, MA, USA).

Techniques: Dominant Negative Mutation, Control, Cytometry